Logo image of LNSR

LENSAR INC (LNSR) Stock Price, Quote, News and Overview

NASDAQ:LNSR - Nasdaq - US52634L1089 - Common Stock - Currency: USD

13.79  -0.12 (-0.86%)

LNSR Quote, Performance and Key Statistics

LENSAR INC

NASDAQ:LNSR (4/21/2025, 8:00:00 PM)

13.79

-0.12 (-0.86%)

Sector
GICS SectorHealth Care
GICS IndustryHealth Care Equipment & Supplies
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Equipment
Statistics
52 Week High17.31
52 Week Low2.95
Market Cap162.58M
Shares11.79M
Float9.29M
Yearly DividendN/A
Dividend YieldN/A
PEN/A
Fwd PEN/A
Earnings (Next)05-07 2025-05-07/bmo
IPO09-21 2020-09-21


LNSR short term performance overview.The bars show the price performance of LNSR in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 50 100 150

LNSR long term performance overview.The bars show the price performance of LNSR in the last 1, 2 and 3 years. 1 year 2 years 3 years 100 200 300

The current stock price of LNSR is 13.79 USD. In the past month the price decreased by -6.95%. In the past year, price increased by 325.62%.

LENSAR INC / LNSR Daily stock chart

LNSR Competitors/Peers

The largest stocks on the US markets in the "Health Care Equipment" sub-industry
Full List
Symbol
Name
TA
FA
PE
Market Cap
ABT ABBOTT LABORATORIES 27.17 225.27B
ISRG INTUITIVE SURGICAL INC 63.89 167.79B
BSX BOSTON SCIENTIFIC CORP 37.28 138.41B
SYK STRYKER CORP 27.86 129.62B
MDT MEDTRONIC PLC 15.32 104.91B
BDX BECTON DICKINSON AND CO 14.13 56.45B
EW EDWARDS LIFESCIENCES CORP 26.41 40.68B
IDXX IDEXX LABORATORIES INC 36.15 32.95B
RMD RESMED INC 23.85 30.97B
GEHC GE HEALTHCARE TECHNOLOGY 13.47 27.69B
DXCM DEXCOM INC 40.07 25.92B
PHG KONINKLIJKE PHILIPS NVR- NY 14.83 21.89B

About LNSR

Company Profile

LNSR logo image LENSAR, Inc. engages in the development of femtosecond laser technology for refractive cataract surgery. The company is headquartered in Orlando, Florida and currently employs 140 full-time employees. The company went IPO on 2020-09-21. The firm is focused on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. Its product portfolio consists of the LENSAR Laser System and ALLY Adaptive Cataract Treatment System (ALLY System) and its associated consumable components. The system incorporates a range of technologies designed to assist the surgeon in obtaining visual outcomes. The consumable portion of the system consists of a disposable patient interface device kit. The ALLY System is designed to combine its femtosecond laser technology features with enhanced laser capabilities into a single small unit that allows surgeons to perform a femtosecond laser assisted cataract procedure in a single operating room or in-office surgical suite. Its system is used across surgeons, hospital outpatient surgical facilities and ambulatory surgery centers.

Company Info

LENSAR INC

2800 Discovery Drive, Suite 100

Orlando FLORIDA 32826 US

CEO: Nicholas Curtis

Employees: 130

Company Website: https://www.lensar.com/

Investor Relations: http://ir.lensar.com/overview/default.aspx

Phone: 18885367271

LENSAR INC / LNSR FAQ

What is the stock price of LENSAR INC today?

The current stock price of LNSR is 13.79 USD. The price decreased by -0.86% in the last trading session.


What is the ticker symbol for LENSAR INC stock?

The exchange symbol of LENSAR INC is LNSR and it is listed on the Nasdaq exchange.


On which exchange is LNSR stock listed?

LNSR stock is listed on the Nasdaq exchange.


What is the price forecast or stock price prediction for LENSAR INC stock?

7 analysts have analysed LNSR and the average price target is 15.3 USD. This implies a price increase of 10.95% is expected in the next year compared to the current price of 13.79. Check the LENSAR INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is LENSAR INC worth?

LENSAR INC (LNSR) has a market capitalization of 162.58M USD. This makes LNSR a Micro Cap stock.


How many employees does LENSAR INC have?

LENSAR INC (LNSR) currently has 130 employees.


What are the support and resistance levels for LENSAR INC (LNSR) stock?

LENSAR INC (LNSR) has a support level at 13.63 and a resistance level at 13.87. Check the full technical report for a detailed analysis of LNSR support and resistance levels.


Is LENSAR INC (LNSR) expected to grow?

The Revenue of LENSAR INC (LNSR) is expected to grow by 31.82% in the next year. Check the estimates tab for more information on the LNSR EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy LENSAR INC (LNSR) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does LENSAR INC (LNSR) stock pay dividends?

LNSR does not pay a dividend.


When does LENSAR INC (LNSR) report earnings?

LENSAR INC (LNSR) will report earnings on 2025-05-07, before the market open.


What is the Price/Earnings (PE) ratio of LENSAR INC (LNSR)?

LENSAR INC (LNSR) does not have a PE ratio as the earnings reported over the last twelve months were negative (-2.72).


What is the Short Interest ratio of LENSAR INC (LNSR) stock?

The outstanding short interest for LENSAR INC (LNSR) is 1.13% of its float. Check the ownership tab for more information on the LNSR short interest.


LNSR Technical Analysis

ChartMill assigns a technical rating of 10 / 10 to LNSR. When comparing the yearly performance of all stocks, LNSR is one of the better performing stocks in the market, outperforming 99.55% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

LNSR Fundamental Analysis

ChartMill assigns a fundamental rating of 3 / 10 to LNSR. LNSR scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

LNSR Financial Highlights

Over the last trailing twelve months LNSR reported a non-GAAP Earnings per Share(EPS) of -2.72. The EPS decreased by -51.96% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -47.37%
ROE -168.42%
Debt/Equity 0
Chartmill High Growth Momentum
EPS Q2Q%-360%
Sales Q2Q%38.22%
EPS 1Y (TTM)-51.96%
Revenue 1Y (TTM)26.87%

LNSR Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 46% to LNSR. The Buy consensus is the average rating of analysts ratings from 7 analysts.

For the next year, analysts expect an EPS growth of 85.38% and a revenue growth 31.82% for LNSR


Ownership
Inst Owners41%
Ins Owners20.14%
Short Float %1.13%
Short Ratio0.95
Analysts
Analysts45.71
Price Target15.3 (10.95%)
EPS Next Y85.38%
Revenue Next Year31.82%